Indefinite Delivery Contract 75N98019D00061

The National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, awarded a $7 million indefinite delivery contract to Murty Pharmaceuticals, Inc., a small disadvantaged minority-owned business, for the development and manufacture of pharmaceutical products to support NIDA's substance abuse and addiction treatment research programs. Under this contract, Murty Pharmaceuticals performs a range of services including formulation development,...

This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Golden State Medical Supply, Inc., a for-profit pharmaceutical manufacturer and distributor. The contract is for the procurement of Metformin HCL IR Tablets, targeting multiple federal agencies including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. The contract has a base period of one year with four...

The National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services, awarded a single-award Indefinite Delivery Contract (IDC) to Polypeptide Laboratories San Diego, LLC (doing business as Polypeptide Labs) in February 2022. The $2,781,317 contract covers the synthesis and distribution of opioid and related peptides over a 5-year period of performance from February 15, 2022 to February 14, 2027. Polypeptide Labs, a specialized manufacturer of...

This indefinite delivery contract (IDC), awarded by the National Institutes of Health National Institute on Drug Abuse (NIDA) to Vitae Enim Vitae Scientific, Inc. (VEV Scientific), provides Chemistry, Manufacturing, and Control (CMC) services to support the development of drug products by the National Center for Advancing Translational Sciences (NCATS). The $49.9M, 7-year contract will deliver a range of preclinical services required for the design, development, manufacture, and release of...

DMS Pharmaceutical Group Inc., a woman-owned small business, holds a single-award indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) under the SPE2DB program, valued at up to $4,999,999 through December 2025. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring...

The key products and services being delivered under this federal Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc. are a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. The IDC, valued at $499,999,999 and valid through November 2026, covers an extensive portfolio of pharmaceutical products including branded and generic prescription drugs, over-the-counter...

The Defense Logistics Agency Troop Support Medical, a defense agency, has awarded Marlex Pharmaceuticals Inc., a minority-owned, self-certified small disadvantaged business, an Indefinite Delivery Contract (IDC) with a ceiling value of $9,215,304.68. The contract is for the manufacture and distribution of a variety of generic pharmaceutical products, including medications such as prednisone, haloperidol, methocarbamol, loratadine, cetirizine, and others, to support federal healthcare programs....

DMS Pharmaceutical Group Inc., a woman-owned small business, holds a single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) under the SPE2DB program, valued at up to $499,999,999 through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring...

The subject federal contract IDV award is a $4,999,999.00 single-award Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract was awarded on April 29, 2015 by the Defense Logistics Agency (DLA) Troop Support Medical and runs through December 31, 2025. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...

The federal contract IDV award is for an Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $499,999,999, provides a vehicle for the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. This...